Relationship between small intestinal bacterial overgrowth and irritable bowel syndrome and the efficacy of rifaximin intervention: a systematic review and meta-analysis.

Although the difference did not reach statistical significance, a trend toward higher eradication rates was observed with medium-to-high doses (≥ 1,200 mg/day; ER = 0.62) compared to lower doses (ER = 0.55).

also in 111,027 other papers